Kindred Biosciences, Inc. (KIN): Price and Financial Metrics
Kindred Biosciences, Inc. (KIN)
Today's Latest Price: $4.09 USD
0.22 (5.68%)
Updated Jul 8 4:00pm
Add KIN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
KIN Stock Summary
- With a price/sales ratio of 36.54, Kindred Biosciences Inc has a higher such ratio than 95.23% of stocks in our set.
- With a year-over-year growth in debt of 1,145.79%, Kindred Biosciences Inc's debt growth rate surpasses 98.21% of about US stocks.
- As for revenue growth, note that KIN's revenue has grown 75.09% over the past 12 months; that beats the revenue growth of 92.69% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to Kindred Biosciences Inc, a group of peers worth examining would be PSNL, MRAM, JG, CERS, and PACB.
- Visit KIN's SEC page to see the company's official filings. To visit the company's web site, go to www.kindredbio.com.
KIN Daily Price Range
KIN 52-Week Price Range
KIN Stock Price Chart Technical Analysis Charts
KIN Price/Volume Stats
| Current price | $4.09 | 52-week high | $11.93 |
| Prev. close | $3.87 | 52-week low | $3.11 |
| Day low | $3.78 | Volume | 212,246 |
| Day high | $4.10 | Avg. volume | 308,595 |
| 50-day MA | $4.62 | Dividend yield | N/A |
| 200-day MA | $6.86 | Market Cap | 160.70M |
Kindred Biosciences, Inc. (KIN) Company Bio
Kindred Biosciences, Inc., a development stage biopharmaceutical company, focuses on the development of therapies for pets. The companys product pipeline consists of small molecules and biologics for a range of indications in dogs, cats, and horses. The company was founded in 2012 and is based in Burlingame, California.
Loading social stream, please wait...